TABLE 3.
Results.
| Panel A: prognosis weeks–months |
Panel B: prognosis months to years |
|||||
|---|---|---|---|---|---|---|
| Round 3 decisiona | Median score | Participant no. | Round 3 decisiona | Median score | Participant No. | |
| A. Continue the patient’s opioid (s) | Appropriate | 7 | 49 | Appropriate | 7 | 52 |
| B. Increase monitoring (e.g., more frequent visits, short prescriptions) | Appropriate | 9 | 49 | Appropriate | 8 | 52 |
| C. Taper the patient’s opioids slowly | Inappropriate | 3 | 40 | Inappropriate | 3 | 51 |
| D. Taper the patient’s opioids rapidly | Inappropriate | 1 | 48 | Inappropriate | 1 | 52 |
| E. Transition the patient to buprenorphine/naloxone | Inappropriate | 3 | 48 | Uncertain | 4 | 51 |
a
Experts used a 9-point Likert scale, from 1 (very inappropriate) to 9 (very appropriate). Decisions were considered appropriate if the median score was 6.5–9, uncertain if the median score was 3.5–6, and inappropriate if the median score was 0–3.5.